510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

Profemur Z Classic Stems

K123434510(k) SpecialCleared Feb 5, 201390-day reviewClass II21 CFR 888.3353Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Wrightmedicaltechnologyinc · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Feb 5, 2013 as substantially equivalent to K111699 (Wrightmedicaltechnologyinc, 2011) and 1 other predicate after a 90-day review. Its family tree reaches back 2 generations to 2001. 2 later devices descend from it. It has been recalled once.

Decided
Feb 5, 2013
Review
90 days
Class
Class II
Product code
LZO
Recalls
1
Predicates
2

Its longest line of descent runs back 2 generations to K004043 (2001). 4 ancestors in all. 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2001: 1 other ancestor2018: 1 descendant cleared2024: 1 descendant clearedK004043 · Metal Transcend Articulation System · Wrightmedicaltechnologyinc · 2001K111699 · Profemur (R) Z Titanium Plasma Sprayed Hip Stem · Wrightmedicaltechnologyinc · 2011200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 1 descendant K111699 · Profemur (R) Z Titanium Plasma Sprayed Hip Stem · Wrightmedicaltechnologyinc · 2011K004043 · Metal Transcend Articulation System · Wrightmedicaltechnologyinc · 20010
  1. Root · 2 generations backK004043 Metal Transcend Articulation SystemWrightmedicaltechnologyinc · 2001
  2. 1 generation backK111699 Profemur (R) Z Titanium Plasma Sprayed Hip StemWrightmedicaltechnologyinc · 2011
  3. This deviceK123434 Profemur Z Classic StemsWrightmedicaltechnologyinc · 2013
  4. Descendant · cites it directly · 1 of its ownK173898 MicroPort Orthopedics Total Hip Systems MR LabelingMicroport Orthopedics Inc. (Mpo) · 2018
  5. Descendant · 2 generations on · 0 of its ownK240452 Ceramic Femoral HeadMicroport Orthopedics, Inc. · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K173898MicroPort Orthopedics Total Hip Systems MR LabelingMicroport Orthopedics Inc. (Mpo) · 2018 · cites it directly1descendant
  • K240452Ceramic Femoral HeadMicroport Orthopedics, Inc. · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K004043Metal Transcend Articulation SystemWrightmedicaltechnologyinc2001—
−1K111699Profemur (R) Z Titanium Plasma Sprayed Hip StemWrightmedicaltechnologyinc2011—
0 (this device)K123434Profemur Z Classic StemsWrightmedicaltechnologyinc2013—
+1K173898MicroPort Orthopedics Total Hip Systems MR LabelingMicroport Orthopedics Inc. (Mpo)2018—
+2K240452Ceramic Femoral HeadMicroport Orthopedics, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
202410
FIG. 1 — Lineage of K123434, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K111699Profemur (R) Z Titanium Plasma Sprayed Hip Stem
Summary page 1
…PROFEMUR® 7 Plasma-Coated Hip Stem, KI 111699 STEM Hip Replacement System,…
Wrightmedicaltechnologyinc2011—
*K021346Stem Hip Replacement System, Model PHA002XX
Summary page 1
…STEM Hip Replacement System, K02 1346 Headquarters Tab 07: Pape I oft3 WVrigh…
Wrightmedicaltechnologyinc20023

Also cleared against K111699: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K173898MicroPort Orthopedics Total Hip Systems MR LabelingMicroport Orthopedics Inc. (Mpo)20181

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 4, 2022Class IIZ-1225-2022Process change controlOne manufacturing lot is missing the plasma-spray coating in the proximal region of the stem body.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 1 company; a new generation was cleared every 10.1 years on median.
  • 2 of the 4 ancestors have a recall of any class.
  • Of its descendants, K173898 (Microport Orthopedics Inc. (Mpo), 2018) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K111699.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

The PROFEMUR® Z Classic Stems are indicated for use in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: 1. non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia; 2. inflammatory degenerative joint disease such as rheumatoid arthritis; 3. correction of functional…

Read the full statement (101 words)

The PROFEMUR® Z Classic Stems are indicated for use in total hip arthroplasty for

reduction or relief of pain and/or improved hip function in skeletally mature patients with

the following conditions:

1. non-inflammatory degenerative joint disease such as osteoarthritis, avascular

necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia;

2. inflammatory degenerative joint disease such as rheumatoid arthritis;

3. correction of functional deformity; and,

4. revision procedures where other treatments or devices have failed.

The PROFEMUR® Z Classic Stems are single use components, intended for use in

conjunction with associated ceramic or metal femoral heads as part of uncemented total

hip arthroplasty.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123434: Profemur Z Classic Stems.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K123434

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026